PACS Group (NYSE:PACS) CEO Sells 232 Shares of Stock

Key Points

• CEO insider selling: PACS Group CEO Jason Murray sold 232 shares at an average price of $45, generating $10,440 under a pre-arranged Rule 10b5-1 trading plan. He still directly owns roughly 54.4 million shares.
• Recent stock performance and results: PACS shares fell 1.7% to $46.93 but remain near their 52-week high of $49.49. The company recently exceeded quarterly estimates, reporting $0.63 in EPS versus $0.54 expected and $1.43 billion in revenue.
• Analyst outlook remains positive: Five analysts rate the stock Buy and two rate it Hold, producing a consensus “Moderate Buy” rating and an average price target of $58.80.

PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 232 shares of the business's stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $45.00, for a total transaction of $10,440.00. Following the sale, the chief executive officer directly owned 54,435,017 shares of the company's stock, valued at $2,449,575,765. This represents a 0.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The stock was sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total transaction of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The shares were sold at an average price of $42.51, for a total transaction of $1,107,470.52.
• On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total transaction of $1,358,606.16.
• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The stock was sold at an average price of $45.03, for a total transaction of $14,274.51.
• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total transaction of $476,226.67.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total transaction of $396,098.36.

PACS Group Trading Down 1.7%

Shares of NYSE PACS traded down $0.82 during trading hours on Friday, reaching $46.93. The stock had a trading volume of 958,006 shares, compared to its average volume of 895,386. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a market cap of $7.43 billion, a price-to-earnings ratio of 27.28, a P/E/G ratio of 1.40 and a beta of -0.08. The business's fifty day moving average price is $43.61 and its two-hundred day moving average price is $40.37. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49.

PACS Group (NYSE:PACS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion for the quarter, compared to analysts' expectations of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Hedge Funds Weigh In On PACS Group

A number of large investors have recently bought and sold shares of the business. Ellsworth Advisors LLC purchased a new stake in PACS Group during the third quarter worth $914,000. State of Alaska Department of Revenue boosted its position in PACS Group by 29.0% during the 3rd quarter. State of Alaska Department of Revenue now owns 6,715 shares of the company's stock valued at $279,000 after acquiring an additional 1,511 shares in the last quarter. GK Wealth Management LLC bought a new stake in PACS Group during the 3rd quarter valued at $41,000. Toth Financial Advisory Corp increased its holdings in shares of PACS Group by 87.5% in the 3rd quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company's stock valued at $62,000 after acquiring an additional 700 shares during the period. Finally, Tidal Investments LLC purchased a new position in shares of PACS Group in the 2nd quarter valued at $252,000.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on PACS shares. Oppenheimer upped their target price on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a report on Monday, August 10th. UBS Group raised their price target on PACS Group from $57.00 to $60.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. Weiss Ratings upgraded PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, October 8th. JPMorgan Chase & Co. upped their price objective on shares of PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research note on Friday, September 4th. Finally, Truist Financial set a $62.00 target price on shares of PACS Group in a report on Wednesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, PACS Group has a consensus rating of "Moderate Buy" and a consensus target price of $58.80.

PACS Group Company Profile

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company's services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.